ScholarLens Back to search
2015•International Journal of Research in Medical SciencesOpen access

Efficacy and safety of triple drug fixed-dose combination of telmisartan, amlodipine and hydrochlorothiazide in the management of hypertension

Maccha Balraj, Arif Ahmed Faruqui

Open full text 6 citations

Abstract

Evidence studies indicate that for every 20mmHg increase in systolic BP, or for every 10mmHg increase in diastolic BP, the risk of cardiovascular disease (CVD)

Open-access reader

About this research paper

What this paper is about

Evidence studies indicate that for every 20mmHg increase in systolic BP, or for every 10mmHg increase in diastolic BP, the risk of cardiovascular disease (CVD)

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Evidence studies indicate that for every 20mmHg increase in systolic BP, or for every 10mmHg increase in diastolic BP, the risk of cardiovascular disease (CVD)

Key concepts: Medicine, Telmisartan, Hydrochlorothiazide, Amlodipine, Fixed-dose combination, Drug, Safety profile, Pharmacology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Efficacy and safety of triple drug fixed-dose combination of telmisartan, amlodipine and hydrochlorothiazide in the management of hypertension — Research Paper | ScholarLens